Infliximab administration prior to surgery does not increase surgical site infections in patients with ulcerative colitis

International Journal of Colorectal Disease

Volumn 28, Issue 9, 2013, Pages 1295-1306

  Uchino, Motoi ^a   Ikeuchi, Hiroki ^a   Matsuoka, Hiroki ^a   Bando, Toshihiro ^a   Ichiki, Kaoru ^a   Nakajima, Kazuhiko ^a   Tomita, Naohiro ^a   Takesue, Yoshio ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Ileal pouch anal anastomosis; Infliximab; Restorative proctocolectomy; Surgical site infection; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AGE; AGED; ANASTOMOSIS FAILURE; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CATHETER INFECTION; CHILD; COLON RESECTION; CONTAMINATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INFECTIOUS COMPLICATION; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NATIONAL NOSOCOMIAL INFECTION SURVEILLANCE RISK INDEX; PANCOLITIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; SCHOOL CHILD; SURGICAL INFECTION; ULCERATIVE COLITIS; URINARY TRACT INFECTION; WOUND ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84883304805     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1700-2     Document Type: Article

References (30)

1. Langholz E, Munkholm P, Davidsen M, Binder V (1992) Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103:1444-1451
2. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462-2476
3. Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T (2010) Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. J Gastroenterol Hepatol 25:886-891
4. Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ (2004) Early postoperative complications are not increased in patients with Crohn's disease treated preoperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878-883
5. Parsi MA, Achkar JP, Richardson S, Katz J, Hammel JP, Lashner BA, Brzezinski A (2002) Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology 123:707-713
6. Marchal L, D'Haens G, Van Assche G, Vermeire S, Noman M, Ferrante M, Hiele M, Bueno De Mesquita M, D'Hoore A, Penninckx F, Rutgeerts P (2004) The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 19:749-754
7. Selvasekar CR, Cima RR, Larson DW, Dozois EJ, Harrington JR, Harmsen WS, Loftus EV Jr, Sandborn WJ, Wolff BG, Pemberton JH (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204:956-962
8. Mor IJ, Vogel JD, da Luz MA, Shen B, Hammel J, Remzi FH (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51:1202-1210
9. Ehteshami-Afshar S, Nikfar S, Rezaie A, Abdollahi M (2011) A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 6:1000-1012
10. Yang Z, Wu Q, Wu K, Fan D (2010) Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 31:486-492
11. Uchino M, Ikeuchi H, Matsuoka H, Tsuchida T, Tomita N, Takesue Y (2010) Risk factors associated with surgical site infection after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum 53:143-149
12. Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, Wagner C, Schaible T, Plevy SE, Targan SR, Rutgeerts P (2001) Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther 15:463-473
13. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606-608
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128-140
15. Truelove SC, Witts LJ (1955) Cortison in ulcerative colitis. Final report on a therapeutic trial. Br Med J 2:1041-1045
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128-140
17. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309-332
18. Sandborn WJ, Loftus EV (2004) Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut 53:780-782
19. Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ (2004) Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878-883
20. den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, de Waal-Malefijt M, van den Hoogen FH (2007) Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 34:689-695
21. Selvasekar CR, Cima RR, Larson DW, Dozois EJ, Harrington JR, Harmsen WS, Loftus EV Jr, Sandborn WJ, Wolff BG, Pemberton JH (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204:956-962
22. Mor IJ, Vogel JD, da Luz MA, Shen B, Hammel J, Remzi FH (2008) Infliximab in ulcerative colitis is associated with an increasing risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51:1201-1210
23. Ehteshami-Afshar S, Nikfar S, Rezaie A, Abdollahi M (2011) A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 6:1000-1012
24. Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, Wagner C, Schaible T, Plevy SE, Targan SR, Rutgeerts P (2001) Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther 15:463-473
25. Lim M, Sagar P, Abdulgader A, Thekkinkattil D, Burke D (2007) The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis. Dis Colon Rectum 50:943-951
26. Ahn HS, Lee SK, Kim HJ, Jang JY, Joo KR, Dong SH, Kim BH, Lee JI, Chang YW, Chang R (2006) Risk of postoperative infection in patients with inflammatory bowel disease. Korean J Gastroenterol 48:306-312
27. Miki C, Ohmori Y, Yoshiyama S, Toiyama Y, Araki T, Uchida K, Kusunoki M (2007) Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients. World J Surg 31:522-529
28. Subramanian V, Pollok RC, Kang JY, Kumar D (2006) Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg 93:793-799
29. Petrosillo N, Drapeau CM, Nicastri E, Martini L, Ippolito G, Moro ML et al (2008) Surgical site infections in Italian hospitals: a prospective multicenter study. BMC Infect Dis 8:34
30. Edwards JP, Ho AL, Tee MC, Dixon E, Ball CG (2012) Wound protectors reduce surgical site infection: a meta-analysis of randomized controlled trials. Ann Surg 256:53-59